Patient stories

Jordan's Story

Jordan, a vibrant 17-year-old, defies the odds with a heart filled with determination, despite congenital heart defects and the challenges of end-stage heart failure and kidney insufficiency. In a remarkable display of hope, doctors implanted a SynCardia Total Artificial Heart (TAH), paving the way for a brighter future and the possibility of a heart transplant.

Jordan was born with multiple congenital heart defects, including congenitally corrected transposition of the great arteries (CCTGA), in which the two ventricles and their attached valves are reversed; pulmonary atresia, in which the valve that controls blood flow from the heart to the lungs doesn’t form at all; and a ventricular septal defect (VSD), a hole in the wall separating the two lower chambers (ventricles) of the heart.


As an infant, Jordan had an ascending aorta-to-main pulmonary artery shunt and an epicardial pacemaker placed. As he grew older, he underwent several surgical revisions and implantation of a defibrillator. But by his teenage years, Jordan’s heart had begun to fail, and he was placed on the waiting list for a heart transplant.


When he was 17, Jordan was admitted to Texas Children’s Hospital with heart failure symptoms and kidney insufficiency. Over the course of the following weeks, he was in and out of the cardiovascular intensive care unit. In May of that year, his condition became dire when all of his organs began to fail and he was placed on a ventilator. To save his life, doctors implanted the SynCardia Total Artificial Heart.


“Jordan was waiting for a donor heart, but both ventricles and two of his valves were failing, and we were running out of time,” said Jordan’s surgeon, Dr. David L.S. Morales. “The SynCardia Total Artificial Heart, which was immediately available when this patient needed it most, could take care of all of these problems with one operation.”


Jordan’s case posed a challenge given his unusual heart structure. When the SynCardia TAH is implanted in a patient with a normally-structured heart, the right and left ventricles are crossed. To adapt to the structural defects of Jordan’s heart, Dr. Morales modified the SynCardia TAH implant technique so that the right and left ventricles were implanted in parallel instead.

Freedom is a TradeMark of SynCardia Systems, LLC

SynCardia Systems, LLC

1992 E. Silverlake Rd. Tucson, AZ 85713
+1 520-545-1234 | info@syncardia.com
www.SynCardia.com

#SynCardia

SynCardia Systems, LLC – a Picard Medical Company

The SynCardia Total Artificial Heart is a treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure.

Medical Advice Disclaimer
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or a qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read on this website.

©  SynCardia Systems, LLC | All rights reserved.

This website makes use of cookies. Please see our Privacy & Cookie Policy for details.

Deny

OK